Ander Francisco Pereira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ander Francisco Pereira has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Teodorico Castro Ramalho
Federal University of Lavras
9 shared publications - Alexandre Alves de Castro
Department of Chemistry, Federal University of Lavras, Lavras 37200-000, Brazil
6 shared publications - Daniel Henriques Soares Leal
Institute of Physics and Chemistry, Federal University of Itajubá, Itajubá, Brazil
4 shared publications - Leandro Martínez
Universidade Estadual de Campinas (UNICAMP)
4 shared publications Elaine F. F. da Cunha
A Laboratory of Molecular Modeling, Department of Chemistry , Federal University of Lavras , Lavras , Brazil
3 shared publicationsElaine F.F. da Cunha
Laboratory of Molecular Modeling, Department of Chemistry, Federal University of Lavras, Lavras, MG, 37200-000, Brazil
3 shared publications
Latest Publications
- Open Access
- 9 November 2026
- Published by Wiley in Protein Science
- Vol. 35 (12)
Distinct roles of monosaccharides in the inhibition of the carbohydrate‐binding module and catalytic domain of Cel7A
The enzymatic breakdown of lignocellulosic biomass is a critical step toward the sustainable production of biochemicals. The cellobiohydrolase Cel7A plays a key role in this process by hydrolyzing cellulose. Both the primary reaction product (cellobiose) and secondary monosaccharides (glucose, mannose, and xylose) inhibit Cel7A's activity by interacting with its carbohydrate‐binding module (CBM) and catalytic domain (CD). Previous works have established that while glucose directly slows the enzyme's catalytic rate ( k cat ), mannose and xylose primarily reduce its association rate ( k on ) and overall processivity. To uncover the microscopic mechanisms behind these observations, we employed all‐atom molecular dynamics simulations combined with the Kirkwood–Buff solution theory. Our results reveal an unsuspected contrast in the solvation preferences of the two domains: while sugars are preferentially excluded from the CD, the CBM exhibits preferential sugar binding. We observed a high density of sugars along the CBM's planar binding face (residues Y5, Y31, and Y32), as well as near I11, S14, S21, V27, L28, and P30. Xylose, the most potent experimental inhibitor, displays the highest density near the CBM residues comprising the cellulose‐binding face, which could interfere with the enzyme's anchoring of cellulose. Furthermore, we observed sugar accumulation at the entrance of the CD tunnel and within the tunnel‐binding loops (B2, B3, and A3), providing a structural explanation for the obstruction of the enzyme's processive cycle. By reconciling broader solvation preferences with highly specific site interactions, our findings offer a picture of how glucose and hemicellulose‐derived sugars inhibit Cel7A.
- 9 November 2026
- Published by Wiley in Protein Science
- Vol. 35 (12)
Open AccessDistinct roles of monosaccharides in the inhibition of the carbohydrate‐binding module and catalytic domain of Cel7A
The enzymatic breakdown of lignocellulosic biomass is a critical step toward the sustainable production of biochemicals. The cellobiohydrolase Cel7A plays a key role in this process by hydrolyzing cellulose. Both the primary reaction product (cellobiose) and secondary monosaccharides (glucose, mannose, and xylose) inhibit Cel7A's activity by interacting with its carbohydrate‐binding module (CBM) and catalytic domain (CD). Previous works have established that while glucose directly slows the enzyme's catalytic rate ( k cat ), mannose and xylose primarily reduce its association rate ( k on ) and overall processivity. To uncover the microscopic mechanisms behind these observations, we employed all‐atom molecular dynamics simulations combined with the Kirkwood–Buff solution theory. Our results reveal an unsuspected contrast in the solvation preferences of the two domains: while sugars are preferentially excluded from the CD, the CBM exhibits preferential sugar binding. We observed a high density of sugars along the CBM's planar binding face (residues Y5, Y31, and Y32), as well as near I11, S14, S21, V27, L28, and P30. Xylose, the most potent experimental inhibitor, displays the highest density near the CBM residues comprising the cellulose‐binding face, which could interfere with the enzyme's anchoring of cellulose. Furthermore, we observed sugar accumulation at the entrance of the CD tunnel and within the tunnel‐binding loops (B2, B3, and A3), providing a structural explanation for the obstruction of the enzyme's processive cycle. By reconciling broader solvation preferences with highly specific site interactions, our findings offer a picture of how glucose and hemicellulose‐derived sugars inhibit Cel7A.
- Open Access
Extending the osmophobic effect to protein side chains with a unified transfer model across osmolyte classes
Understanding the role of the protein backbone and side chains on cosolvent-induced stabilization is essential for a molecular picture of osmolyte action. The dominant view has been that protecting osmolytes stabilize proteins primarily through unfavorable interactions with the peptide backbone - the osmophobic effect - with side chains playing a minor or opposing role. By revisiting the decomposition of amino acid transfer free energies with proper account of the mutual shielding between backbone and side-chain groups, we derive a transfer model that is consistent with experimental denaturation m -values for urea and protecting osmolytes simultaneously - a feat neither the established nor the previously proposed universal-backbone models could achieve alone. A mechanism-dependent interpretation of backbone accessibility is proposed: geometric for excluded cosolvents, complete for binders where cosolvent-backbone interactions are specific. The model reveals that for all strong protecting osmolytes, including TMAO, sarcosine, sucrose, trehalose, and sorbitol, both backbone and side chains contribute favorably to protein stabilization, with side-chain contributions comparable to or exceeding those of the backbone. For urea, the model recovers the known balanced backbone and side-chain contributions to denaturation when the directional nature of urea-backbone hydrogen bonding is accounted for, which makes the backbone accessible to urea regardless of side-chain shielding. Weaker protectants such as proline, betaine, and glycerol are distinguished by competing backbone and side-chain effects that partially cancel. These results extend the osmophobic effect to protein side chains and establish a three-tier classification of osmolyte action: cooperative backbone and side-chain stabilization, cooperative destabilization, and competing contributions. The greater sensitivity of the model predictions to side-chain composition provides avenues for experimental validation of the underlying physical assumptions and for protein engineering.
Open AccessExtending the osmophobic effect to protein side chains with a unified transfer model across osmolyte classes
Understanding the role of the protein backbone and side chains on cosolvent-induced stabilization is essential for a molecular picture of osmolyte action. The dominant view has been that protecting osmolytes stabilize proteins primarily through unfavorable interactions with the peptide backbone - the osmophobic effect - with side chains playing a minor or opposing role. By revisiting the decomposition of amino acid transfer free energies with proper account of the mutual shielding between backbone and side-chain groups, we derive a transfer model that is consistent with experimental denaturation m -values for urea and protecting osmolytes simultaneously - a feat neither the established nor the previously proposed universal-backbone models could achieve alone. A mechanism-dependent interpretation of backbone accessibility is proposed: geometric for excluded cosolvents, complete for binders where cosolvent-backbone interactions are specific. The model reveals that for all strong protecting osmolytes, including TMAO, sarcosine, sucrose, trehalose, and sorbitol, both backbone and side chains contribute favorably to protein stabilization, with side-chain contributions comparable to or exceeding those of the backbone. For urea, the model recovers the known balanced backbone and side-chain contributions to denaturation when the directional nature of urea-backbone hydrogen bonding is accounted for, which makes the backbone accessible to urea regardless of side-chain shielding. Weaker protectants such as proline, betaine, and glycerol are distinguished by competing backbone and side-chain effects that partially cancel. These results extend the osmophobic effect to protein side chains and establish a three-tier classification of osmolyte action: cooperative backbone and side-chain stabilization, cooperative destabilization, and competing contributions. The greater sensitivity of the model predictions to side-chain composition provides avenues for experimental validation of the underlying physical assumptions and for protein engineering.
- Open Access
- 13 October 2025
- Published by American Chemical Society (ACS) in JACS Au
- Vol. 5 (12) , 6025-6041
Osmolyte Structural and Thermodynamic Effects Across the Protein Folding Landscape
In this work, the structure and thermodynamics of urea and trimethylamine N-oxide (TMAO) preferential interactions across the complete folding landscape of the β-sheet SRC Homology 3 (SH3) domain and the helical B domain of protein A (BdpA) are characterized. There is a high correlation between preferential interactions and the surface area of the denatured states, despite the chemical nature of the exposed surfaces upon denaturation differing from those of native states. For SH3, the denaturation always proceeds with an increase in surface area, such that the qualitative effect of cosolvents on the stability of all denatured states can be inferred from the preferential interactions in the native state. On the other hand, for BdpA, partially denatured states exist that are destabilized by urea; thus, unfolding pathways can be modulated by the cosolvent. Both urea and TMAO form hydrogen bonds with the proteins, which are on average weakened upon denaturation, and nonspecific interactions, which are strengthened in unfolded structures. Backbone, side chain, and specific residue contributions to distribution functions are obtained, illustrating, for instance, the crucial participation of urea-backbone and nonpolar–cosolvent interactions in the solvation mechanisms, on a residue basis. Obtaining these results was possible using a novel computational pipeline to represent solvation structures throughout complete folding landscapes by means of coarse-grained and atomistic simulations and, crucially, the analysis of solvation using minimum-distance distribution functions and the Kirkwood–Buff solvation theory. Cosolvent effects on transfer free energies match experimental data within 1 kcal mol–1, supporting the nuanced description of the osmolyte-protein interplay. The proposed methods can be applied to the study of solvation structure and thermodynamics in other complex molecular systems undergoing large conformational variations, such as nonbiological macromolecules and aggregates.
- 13 October 2025
- Published by American Chemical Society (ACS) in JACS Au
- Vol. 5 (12) , 6025-6041
Open AccessOsmolyte Structural and Thermodynamic Effects Across the Protein Folding Landscape
In this work, the structure and thermodynamics of urea and trimethylamine N-oxide (TMAO) preferential interactions across the complete folding landscape of the β-sheet SRC Homology 3 (SH3) domain and the helical B domain of protein A (BdpA) are characterized. There is a high correlation between preferential interactions and the surface area of the denatured states, despite the chemical nature of the exposed surfaces upon denaturation differing from those of native states. For SH3, the denaturation always proceeds with an increase in surface area, such that the qualitative effect of cosolvents on the stability of all denatured states can be inferred from the preferential interactions in the native state. On the other hand, for BdpA, partially denatured states exist that are destabilized by urea; thus, unfolding pathways can be modulated by the cosolvent. Both urea and TMAO form hydrogen bonds with the proteins, which are on average weakened upon denaturation, and nonspecific interactions, which are strengthened in unfolded structures. Backbone, side chain, and specific residue contributions to distribution functions are obtained, illustrating, for instance, the crucial participation of urea-backbone and nonpolar–cosolvent interactions in the solvation mechanisms, on a residue basis. Obtaining these results was possible using a novel computational pipeline to represent solvation structures throughout complete folding landscapes by means of coarse-grained and atomistic simulations and, crucially, the analysis of solvation using minimum-distance distribution functions and the Kirkwood–Buff solvation theory. Cosolvent effects on transfer free energies match experimental data within 1 kcal mol–1, supporting the nuanced description of the osmolyte-protein interplay. The proposed methods can be applied to the study of solvation structure and thermodynamics in other complex molecular systems undergoing large conformational variations, such as nonbiological macromolecules and aggregates.
- 11 October 2025
- Published by Wiley in Protein Science
- Vol. 34 (11) , e70329
Mapping the energy landscape of a fold‐switching protein MAD2
The mitotic arrest deficiency 2 (MAD2) exists in inactive and active forms under physiologic conditions. In its active conformation, MAD2 binds to the cell division cycle protein 20 (Cdc20) and prevents the separation of duplicated chromosomes. In the inactive conformation, the C‐terminal region of MAD2 covers the binding motif for the Cdc20 target. Here, we investigated the MAD2 activation mechanism using structure‐based models (SBMs) simulations, amino acid coevolution, and structural frustration analysis. MAD2 switches between active and inactive conformations while maintaining core stability. Simulations reveal an intermediate state during the transition consistent with recent time‐resolved NMR experiments. Coevolution analysis captures native contacts for both states. These native contacts, present in both conformations, compete, driving transitions between different protein states. This competition leads to a frustrated energy landscape. Frustration analysis further shows that highly frustrated residues are present in both conformations, particularly in the fold‐switching segments.
- 11 October 2025
- Published by Wiley in Protein Science
- Vol. 34 (11) , e70329
Mapping the energy landscape of a fold‐switching protein MAD2
The mitotic arrest deficiency 2 (MAD2) exists in inactive and active forms under physiologic conditions. In its active conformation, MAD2 binds to the cell division cycle protein 20 (Cdc20) and prevents the separation of duplicated chromosomes. In the inactive conformation, the C‐terminal region of MAD2 covers the binding motif for the Cdc20 target. Here, we investigated the MAD2 activation mechanism using structure‐based models (SBMs) simulations, amino acid coevolution, and structural frustration analysis. MAD2 switches between active and inactive conformations while maintaining core stability. Simulations reveal an intermediate state during the transition consistent with recent time‐resolved NMR experiments. Coevolution analysis captures native contacts for both states. These native contacts, present in both conformations, compete, driving transitions between different protein states. This competition leads to a frustrated energy landscape. Frustration analysis further shows that highly frustrated residues are present in both conformations, particularly in the fold‐switching segments.
- Open Access
Osmolyte structural and thermodynamic effects across the protein folding landscape
In this work, the structure and thermodynamics of urea and TMAO preferential interactions across the complete folding landscape of the β-sheet SH3 domain and the helical B domain of protein A (BdpA) are characterized. There is a high correlation between preferential interactions and the surface area of the denatured states, despite the fact that the chemical nature of the exposed surfaces upon denaturation differs from those of native states. For SH3, the denaturation always proceeds with an increase in surface area, such that the qualitative effect of cosolvents on the stability of all denatured states can be inferred from the preferential interactions in the native state. On the other hand, for BdpA, partially denatured states exist that are destabilized by urea; thus, unfolding pathways can be modulated by the cosolvent. Both urea and TMAO form hydrogen bonds with the proteins, which are weakened upon denaturation, and nonspecific interactions, which are strengthened in unfolded structures. Backbone, side chain, and specific residue contributions to distribution functions are obtained, illustrating, for instance, the crucial participation of urea-backbone and nonpolar-cosolvent interactions in the solvation mechanisms. Obtaining these results was possible using a novel computational pipeline to represent solvation structures throughout complete folding landscapes by means of coarse-grained and atomistic simulations and, crucially, the analysis of solvation using minimum-distance distribution functions and the Kirkwood-Buff solvation theory. Cosolvent effects on transfer free energies match experimental data within 1 kcal mol -1 , supporting the nuanced description of the osmolyte-protein interplay. The proposed methods can be applied to the study of solvation structure and thermodynamics in other complex molecular systems undergoing large conformational variations, such as non-biological macromolecules and aggregates.
Open AccessOsmolyte structural and thermodynamic effects across the protein folding landscape
In this work, the structure and thermodynamics of urea and TMAO preferential interactions across the complete folding landscape of the β-sheet SH3 domain and the helical B domain of protein A (BdpA) are characterized. There is a high correlation between preferential interactions and the surface area of the denatured states, despite the fact that the chemical nature of the exposed surfaces upon denaturation differs from those of native states. For SH3, the denaturation always proceeds with an increase in surface area, such that the qualitative effect of cosolvents on the stability of all denatured states can be inferred from the preferential interactions in the native state. On the other hand, for BdpA, partially denatured states exist that are destabilized by urea; thus, unfolding pathways can be modulated by the cosolvent. Both urea and TMAO form hydrogen bonds with the proteins, which are weakened upon denaturation, and nonspecific interactions, which are strengthened in unfolded structures. Backbone, side chain, and specific residue contributions to distribution functions are obtained, illustrating, for instance, the crucial participation of urea-backbone and nonpolar-cosolvent interactions in the solvation mechanisms. Obtaining these results was possible using a novel computational pipeline to represent solvation structures throughout complete folding landscapes by means of coarse-grained and atomistic simulations and, crucially, the analysis of solvation using minimum-distance distribution functions and the Kirkwood-Buff solvation theory. Cosolvent effects on transfer free energies match experimental data within 1 kcal mol -1 , supporting the nuanced description of the osmolyte-protein interplay. The proposed methods can be applied to the study of solvation structure and thermodynamics in other complex molecular systems undergoing large conformational variations, such as non-biological macromolecules and aggregates.
- Open Access
- 27 March 2023
- Published by American Chemical Society (ACS) in ChemRxiv
Evaluation of autophagy inhibition to combat cancer: (vanadium complex)–protein interactions, parameterization, and validation of a new force field
Autophagy has drawn attention from the scientific community, mainly because of its significant advantages over chemotherapeutic processes. One of these advantages is its direct action on cancer cells, avoiding possible side effects, unlike chemotherapy, which reaches tumor cells and affects healthy cells in the body, leading to a great loss in the quality of life of patients. In this way, it is known that vanadium complex (VC) [VO(oda)(phen)] has proven inhibition effect on autophagy process in pancreatic cancer cells. Keeping that in mind, Molecular Dynamics (MD) simulations can be considered excellent strategies to investigate the interaction of metal complexes and their biological targets. However, simulations of this type are strongly dependent on the appropriate choice of force field (FF). Therefore, this work proposes the development of AMBER FF parameters for VC, having a minimum energy structure as a starting point, obtained through DFT calculations with B3LYP/def2-TZVP level of theory plus ECP for the vanadium atom. An MD simulation in vacuum was performed to validate the developed FF. From the structural analyses, satisfying values of VC bond lengths and angles were obtained, where a good agreement with the experimental data and the quantum reference was found. The RMSD analysis showed an average of only 0.3%. Finally, we performed docking and MD (120 ns) simulations with explicit solvent between VC and PI3K. Overall, our findings encourage new parameterizations of metal complexes with significant biological applications, as well as allow to contribute to the elucidation of the complex process of autophagy.
- 27 March 2023
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessEvaluation of autophagy inhibition to combat cancer: (vanadium complex)–protein interactions, parameterization, and validation of a new force field
Autophagy has drawn attention from the scientific community, mainly because of its significant advantages over chemotherapeutic processes. One of these advantages is its direct action on cancer cells, avoiding possible side effects, unlike chemotherapy, which reaches tumor cells and affects healthy cells in the body, leading to a great loss in the quality of life of patients. In this way, it is known that vanadium complex (VC) [VO(oda)(phen)] has proven inhibition effect on autophagy process in pancreatic cancer cells. Keeping that in mind, Molecular Dynamics (MD) simulations can be considered excellent strategies to investigate the interaction of metal complexes and their biological targets. However, simulations of this type are strongly dependent on the appropriate choice of force field (FF). Therefore, this work proposes the development of AMBER FF parameters for VC, having a minimum energy structure as a starting point, obtained through DFT calculations with B3LYP/def2-TZVP level of theory plus ECP for the vanadium atom. An MD simulation in vacuum was performed to validate the developed FF. From the structural analyses, satisfying values of VC bond lengths and angles were obtained, where a good agreement with the experimental data and the quantum reference was found. The RMSD analysis showed an average of only 0.3%. Finally, we performed docking and MD (120 ns) simulations with explicit solvent between VC and PI3K. Overall, our findings encourage new parameterizations of metal complexes with significant biological applications, as well as allow to contribute to the elucidation of the complex process of autophagy.
- 4 November 2020
- Published by Wiley in International Journal of Quantum Chemistry
- Vol. 121 (6)
Parameterization and validation of a new force field for Pt(II) complexes of 2‐(4′‐amino‐2′‐hydroxyphenyl)benzothiazole
Understanding the ways of interaction of a drug with a biological target is crucial in the pharmacology field. One methodology that allows the simulation of new drugs under in vitro conditions is the classical molecular dynamics (MD) method. However, MD simulations in systems containing metallodrugs are challenging due to the lack of specific parameters found in the literature. In this work, we propose and model a new possible anticancer platinum(II) complex: cis‐dichloro(2‐aminomethylpyridine)platinum(II) bonded to 2‐(4′‐amino‐2′‐hydroxyphenyl)benzothiazole (AHBT). The developed model consists of a new set of AMBER force field parameters based on density functional theory (DFT) calculations. The extensive validation of the parameter set shows that it adequately describes the structural properties of the complex. Overall, we expect this work to contribute significantly to future MD simulations of Pt(II) complexes in biological targets that are still not well explored, mainly due to the few parameters found in the literature.
- 4 November 2020
- Published by Wiley in International Journal of Quantum Chemistry
- Vol. 121 (6)
Parameterization and validation of a new force field for Pt(II) complexes of 2‐(4′‐amino‐2′‐hydroxyphenyl)benzothiazole
Understanding the ways of interaction of a drug with a biological target is crucial in the pharmacology field. One methodology that allows the simulation of new drugs under in vitro conditions is the classical molecular dynamics (MD) method. However, MD simulations in systems containing metallodrugs are challenging due to the lack of specific parameters found in the literature. In this work, we propose and model a new possible anticancer platinum(II) complex: cis‐dichloro(2‐aminomethylpyridine)platinum(II) bonded to 2‐(4′‐amino‐2′‐hydroxyphenyl)benzothiazole (AHBT). The developed model consists of a new set of AMBER force field parameters based on density functional theory (DFT) calculations. The extensive validation of the parameter set shows that it adequately describes the structural properties of the complex. Overall, we expect this work to contribute significantly to future MD simulations of Pt(II) complexes in biological targets that are still not well explored, mainly due to the few parameters found in the literature.
- Open Access
- 27 January 2020
- Published by MDPI AG in Biomolecules
- Vol. 10 (2) , 192
Reactivation of VX-Inhibited Human Acetylcholinesterase by Deprotonated Pralidoxime. A Complementary Quantum Mechanical Study
In the present work, we performed a complementary quantum mechanical (QM) study to describe the mechanism by which deprotonated pralidoxime (2-PAM) could reactivate human (Homo sapiens sapiens) acetylcholinesterase (HssAChE) inhibited by the nerve agent VX. Such a reaction is proposed to occur in subsequent addition–elimination steps, starting with a nucleophile bimolecular substitution (SN2) mechanism through the formation of a trigonal bipyramidal transition state (TS). A near attack conformation (NAC), obtained in a former study using molecular mechanics (MM) calculations, was taken as a starting point for this project, where we described the possible formation of the TS. Together, this combined QM/MM study on AChE reactivation shows the feasibility of the reactivation occurring via attack of the deprotonated form of 2-PAM against the Ser203-VX adduct of HssAChE.
- 27 January 2020
- Published by MDPI AG in Biomolecules
- Vol. 10 (2) , 192
Open AccessReactivation of VX-Inhibited Human Acetylcholinesterase by Deprotonated Pralidoxime. A Complementary Quantum Mechanical Study
In the present work, we performed a complementary quantum mechanical (QM) study to describe the mechanism by which deprotonated pralidoxime (2-PAM) could reactivate human (Homo sapiens sapiens) acetylcholinesterase (HssAChE) inhibited by the nerve agent VX. Such a reaction is proposed to occur in subsequent addition–elimination steps, starting with a nucleophile bimolecular substitution (SN2) mechanism through the formation of a trigonal bipyramidal transition state (TS). A near attack conformation (NAC), obtained in a former study using molecular mechanics (MM) calculations, was taken as a starting point for this project, where we described the possible formation of the TS. Together, this combined QM/MM study on AChE reactivation shows the feasibility of the reactivation occurring via attack of the deprotonated form of 2-PAM against the Ser203-VX adduct of HssAChE.
- 1 August 2019
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 308, 323-331
Development of technologies applied to the biodegradation of warfare nerve agents: Theoretical evidence for asymmetric homogeneous catalysis
- 1 August 2019
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 308, 323-331
Development of technologies applied to the biodegradation of warfare nerve agents: Theoretical evidence for asymmetric homogeneous catalysis
- 29 April 2019
- Published by Taylor & Francis in Expert Review of Neurotherapeutics
- Vol. 19 (5) , 375-395
Non-conventional compounds with potential therapeutic effects against Alzheimer’s disease
Introduction: Alzheimer’s disease (AD) is the most common cause of dementia. Clinical progress in this pathogenesis field has drawn the attention of researchers, stimulating the investigation of novel treatment methods. Current therapies that deal with cholinesterase inhibitors and/or NMDA antagonists have shown a modest symptomatic potential, increasing the need for research into more efficient therapeutics. The goal of this review is to summarize the advances in, and the potential of, non-conventional therapies in AD treatment. Areas covered: In this review, the authors describe the current status of unusual therapies in AD treatment, evaluating the modern scientific contexts in which these therapies have been developed. The authors also highlight the usage of methylene blue, natural products, organophosphorus compounds and Chinese medicine, along with the employment of nanotechnology. Expert opinion: The potential therapies discussed in this review will play increasingly important roles in the prevention and treatment of AD, improving disease management and quality of life for AD patients. Given the annual increasing number of people with dementia, it is crucial to invest in the search for novel therapeutics. In addition, more sophisticated diagnosis techniques are also essential, to allow for an early diagnosis and treatment.
- 29 April 2019
- Published by Taylor & Francis in Expert Review of Neurotherapeutics
- Vol. 19 (5) , 375-395
Non-conventional compounds with potential therapeutic effects against Alzheimer’s disease
Introduction: Alzheimer’s disease (AD) is the most common cause of dementia. Clinical progress in this pathogenesis field has drawn the attention of researchers, stimulating the investigation of novel treatment methods. Current therapies that deal with cholinesterase inhibitors and/or NMDA antagonists have shown a modest symptomatic potential, increasing the need for research into more efficient therapeutics. The goal of this review is to summarize the advances in, and the potential of, non-conventional therapies in AD treatment. Areas covered: In this review, the authors describe the current status of unusual therapies in AD treatment, evaluating the modern scientific contexts in which these therapies have been developed. The authors also highlight the usage of methylene blue, natural products, organophosphorus compounds and Chinese medicine, along with the employment of nanotechnology. Expert opinion: The potential therapies discussed in this review will play increasingly important roles in the prevention and treatment of AD, improving disease management and quality of life for AD patients. Given the annual increasing number of people with dementia, it is crucial to invest in the search for novel therapeutics. In addition, more sophisticated diagnosis techniques are also essential, to allow for an early diagnosis and treatment.